about
sameAs
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsEvaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humansWnt Drug Discovery: Weaving Through the Screens, Patents and Clinical TrialsReduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.Targeting kinase signaling pathways with constrained peptide scaffolds.Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma.Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progressionRacial disparity in metabolic regulation of cancer.Mitogenic signaling pathways in the liver of growth hormone (GH)-overexpressing mice during the growth periodThe Function of V-ATPases in CancerPKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.MEK inhibitors against MET-amplified non-small cell lung cancerFibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer.The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer.Comprehensive review on cardio-oncology: Role of multimodality imaging.Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies.Small GTPase Rab8a-recruited Phosphatidylinositol 3-Kinase γ Regulates Signaling and Cytokine Outputs from Endosomal Toll-like Receptors.Uncarboxylated Osteocalcin Induces Antitumor Immunity against Mouse Melanoma Cell Growth.Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.Lysosome trafficking is necessary for EGF-driven invasion and is regulated by p38 MAPK and Na+/H+ exchangers.Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP.Feedback regulation of RTK signaling in development.Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AML.Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo.Potential Sabotage of Host Cell Physiology by Apicomplexan Parasites for Their Survival Benefits.Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.EGFR-TKIs resistance via EGFR-independent signaling pathways.Advances in studies of tyrosine kinase inhibitors and their acquired resistance.The role of RICTOR downstream of receptor tyrosine kinase in cancers.FGF2-mediated attenuation of myofibroblast activation is modulated by distinct MAPK signaling pathways in human dermal fibroblasts.BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.
P2860
Q26738643-148F61E1-6E62-4F73-A48B-CE3121B33351Q27908506-51C90932-8D39-4D4C-8953-CE278E155A63Q28078703-C9245758-DA64-495D-85AC-BFD7BC69B23AQ30234584-9B5DD5F4-E474-46BF-98C5-5BEE792EFD77Q30398451-B8407BF2-359F-4DCF-8831-E0ADFEC9EFF7Q33743268-AF85F87C-1D5F-484D-990D-F2D70A2C3DF3Q33829484-57799123-FD64-4F3F-9B84-C410763AD4AAQ33845027-675540EB-14B3-45DC-88CF-30A99BED897DQ33866927-24A91039-DB5F-41D0-9A64-D5F02CE69817Q33906704-E162BC78-C836-4E79-9E07-BE3B5AD04173Q36838387-C1566604-F49E-485F-96CF-F73F2EE8E9B8Q37169505-4D6D1E6D-CE66-4768-A8C7-ECD652B8C3ECQ37376230-70AF3F70-1414-4A79-86B4-34E172343388Q37427045-44795DD8-F539-4A97-AC10-81990A5AD433Q38637138-ABC3B38D-CD29-4658-A298-3FB031E80A04Q38718209-4C30DB75-1F9B-4C29-912E-AE92A5872583Q38792120-B80E2503-9771-4986-AEE8-8516E443A9DEQ38844387-D7B1745E-6453-454A-B6B3-C03869477D41Q38925022-AE4AC553-1CB9-48C5-9AAF-F0C1E986A363Q40355358-B0A970E9-FBA2-4480-967B-5D8F7730FE6BQ41243255-C09B1C58-1649-485F-B522-6FB8A23A42F4Q41768870-3E1299D0-B9AC-4BD1-9301-CE209AF6D79BQ42278930-CF4A2C99-75B5-4252-B2F4-FA28A33FD926Q45559181-9DB8EEE3-0924-4AA1-A122-2AC33174DC28Q46578462-6BA94246-C5EF-42E9-BABB-8FBCC6F01ECCQ47110722-B9A0F181-48D0-4700-8ED0-E846BC40CF6CQ47123875-0FC2D885-21F3-44C2-AC6A-7CF1AC362D1FQ47134278-7C87514E-6730-46BC-B050-BCC4E70CB813Q48095542-BEFE8168-B551-4423-90C0-A50B98172BE6Q49581426-486813BD-D237-4ABB-873B-8F7772F32836Q49887890-58DEC493-6A2E-4320-AA7C-4FFAC615104EQ49887903-67016776-BC96-4A55-9B9C-82E226F99A6AQ49887908-45114AEB-130E-44AA-AB6C-A24A064E288CQ50128937-3FB85FD6-04A8-4F54-8F78-71F28AC6F903Q53705974-74297D57-7883-4E03-B55C-1770B4DF5FE6Q54113343-6AE5D3AD-6A72-4C2D-BE09-4F4480482561
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting RTK Signaling Pathways in Cancer
@ast
Targeting RTK Signaling Pathways in Cancer
@en
Targeting RTK Signaling Pathways in Cancer
@nl
type
label
Targeting RTK Signaling Pathways in Cancer
@ast
Targeting RTK Signaling Pathways in Cancer
@en
Targeting RTK Signaling Pathways in Cancer
@nl
prefLabel
Targeting RTK Signaling Pathways in Cancer
@ast
Targeting RTK Signaling Pathways in Cancer
@en
Targeting RTK Signaling Pathways in Cancer
@nl
P2860
P3181
P356
P1433
P1476
Targeting RTK Signaling Pathways in Cancer
@en
P2093
Tarik Regad
P2860
P304
P3181
P356
10.3390/CANCERS7030860
P407
P50
P577
2015-09-03T00:00:00Z